Select Medical Holdings Corporation $SEM Shares Purchased by Price T Rowe Associates Inc. MD

Key Points

• Price T Rowe Associates Inc. MD increased its holdings in Select Medical Holdings Corporation by 1.5%, owning approximately 13.81% of the company after acquiring 270,488 shares in the first quarter.
• Select Medical announced a quarterly dividend of $0.0625 per share, with a yield of 1.9%, to be paid on August 28th.
• The company posted earnings of $0.32 per share in its latest quarter, exceeding expectations, and set a 2025 EPS guidance of 1.090-1.19.

Price T Rowe Associates Inc. MD increased its holdings in shares of Select Medical Holdings Corporation (NYSE:SEM - Free Report) by 1.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,755,298 shares of the health services provider's stock after purchasing an additional 270,488 shares during the period. Price T Rowe Associates Inc. MD owned 13.81% of Select Medical worth $296,515,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. SG Americas Securities LLC boosted its position in Select Medical by 151.0% during the 1st quarter. SG Americas Securities LLC now owns 37,684 shares of the health services provider's stock worth $629,000 after purchasing an additional 22,671 shares during the period. Allspring Global Investments Holdings LLC boosted its position in Select Medical by 47.5% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 24,450 shares of the health services provider's stock worth $403,000 after purchasing an additional 7,871 shares during the period. Janney Montgomery Scott LLC purchased a new stake in Select Medical during the 1st quarter worth $416,000. GAMMA Investing LLC boosted its position in Select Medical by 217.4% during the 1st quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider's stock worth $109,000 after purchasing an additional 4,453 shares during the period. Finally, Ritholtz Wealth Management purchased a new stake in Select Medical during the 1st quarter worth $460,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the stock. Royal Bank Of Canada decreased their price objective on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. UBS Group reissued a "neutral" rating and issued a $14.00 price objective (down from $15.00) on shares of Select Medical in a research report on Monday, August 4th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $20.25.

Select Medical Stock Up 1.6%

Shares of SEM stock traded up $0.21 during trading hours on Wednesday, hitting $13.05. 802,351 shares of the company were exchanged, compared to its average volume of 1,136,791. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.15 and a current ratio of 1.15. Select Medical Holdings Corporation has a one year low of $11.65 and a one year high of $40.98. The business's 50-day simple moving average is $13.97 and its two-hundred day simple moving average is $15.62. The stock has a market capitalization of $1.62 billion, a price-to-earnings ratio of 12.31, a P/E/G ratio of 0.54 and a beta of 1.25.

Select Medical (NYSE:SEM - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping the consensus estimate of $0.28 by $0.04. Select Medical had a net margin of 2.37% and a return on equity of 8.87%. The business had revenue of $1.34 billion for the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter last year, the company posted $0.60 earnings per share. The company's quarterly revenue was up 4.5% compared to the same quarter last year. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. Sell-side analysts predict that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 28th. Stockholders of record on Wednesday, August 13th will be given a dividend of $0.0625 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. Select Medical's dividend payout ratio (DPR) is presently 23.58%.

Select Medical declared that its Board of Directors has approved a stock repurchase program on Thursday, May 1st that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.